Search results

Sort By:

Limit search:

WPŁYW NOWEJ USTAWY O PRODUKTACH KOSMETYCZNYCH NA POPRAWĘ BEZPIECZEŃSTWA ICH STOSOWANIA

100%

Pilarska A., Zimmermann A. E.

Farmacja Polska

2020

vol. 75

issue 12

698-703

Cosmetic products are one of three categories of products that are associated with purchasing in pharmacies. This is mainly due to the high level of confidence in products bought in pharmacies and personal conviction concerning their safety. In fact, the requirements for cosmetics safety are the same for products sold in pharmacies, as well as in any other places. Frequently patients buying cosmetics in pharmacies have no awareness of the fact, that this category of products is regulated differently from medicinal products. It is crucial for patients, who have doubts about the safety of the products, to be able to obtain the necessary information from the pharmacist especially on how and to whom the adverse reaction should be reported. This study analyses the new act on cosmetic products, which has been enacted on January 1, 2019. It contains provisions that are to be an effective enforcement instrument for entities placing cosmetic products on the market to ensure compliance with the relevant obligations set out in Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30th November 2009 on cosmetic products. Cosmetic products are one of three categories of products that are associated with purchasing in pharmacies. This is mainly due to the high level of confidence in products bought in pharmacies and personal conviction concerning their safety. In fact, the requirements for cosmetics safety are the same for products sold in pharmacies, as well as in any other places. Frequently patients buying cosmetics in pharmacies have no awareness of the fact, that this category of products is regulated differently from medicinal products. It is crucial for patients, who have doubts about the safety of the products, to be able to obtain the necessary information from the pharmacist especially on how and to whom the adverse reaction should be reported. This study analyses the new act on cosmetic products, which has been enacted on January 1, 2019. It contains provisions that are to be an effective enforcement instrument for entities placing cosmetic products on the market to ensure compliance with the relevant obligations set out in Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30th November 2009 on cosmetic products.

Produkty kosmetyczne znajdują się w pierwszej trójce kategorii produktów kojarzonych z zakupami dokonywanymi w aptece. Wynika to przede wszystkim z wysokiego poziomu zaufania do produktów kupowanych w aptece i przekonania, że produkt apteczny jest produktem bezpiecznym. W rzeczywistości wymagania dotyczące bezpieczeństwa kosmetyków są takie same dla produktów sprzedawanych w aptekach, jak i w każdym innym miejscu. Niejednokrotnie pacjenci kupujący kosmetyki w aptece nie mają także świadomości, że ta kategoria produktów uregulowana jest w odmienny sposób od produktów leczniczych, czy wyrobów medycznych. Warto, by w sytuacji, gdy pacjenci mający wątpliwości co do bezpieczeństwa zastosowanego produktu, mogli uzyskać od farmaceuty informacje, w jaki sposób i do kogo należy zgłosić działanie niepożądane kosmetyku. Niniejsze opracowanie analizuje nową ustawę o produktach kosmetycznych, która weszła w życie 1 stycznia 2019 r. Zawiera ona zapisy, które mają stanowić narzędzie do skutecznego egzekwowania od podmiotów wprowadzających produkty kosmetyczne do obrotu, przestrzegania przepisów Rozporządzenia Parlamentu Europejskiego i Rady (WE) nr 1223/2009 z 30 listopada 2009 r. dotyczącego produktów kosmetycznych.

Limitation of patients’ rights during the COVID-19 pandemic in Poland

81%

Piątkowska K., Zimmermann A., Pilarska A.

European Journal of Translational and Clinical Medicine

2021

vol. 4

issue 1

79-85

Background: The COVID-19 pandemic has had an impact on the observance and limitation of patients’ rights all over the world, including Poland. Material and methods: We analysed in detail the Polish legal acts relevant to healthcare in terms of their impact on the patients’ rights. Our analysis is based on the Bill of Patients’ Rights that was in force in Poland before the announcement of the state of epidemic (March 20th 2020). The legal acts were analysed by use of the exegesis of legal texts and comparative legal literature rules. Results: The patients’ right to family life and presence of relatives during the performance of healthcare services and to additional nursing care has been directly limited. Rights that have been limited indirectly include the right to healthcare services (limited by the use of telemedicine) and the right to dignified death and pastoral care (patients often die alone). The limitations also have an indirect impact on the right to confidentiality and respect for privacy and dignity. Conclusions: Our analysis identified limited patients’ rights in Poland without entitlement to pursue claims thereunder.

Refine search results

1 European Journal of Translational and Clinical Medicine

1 Farmacja Polska

1 2021

1 2020

2 Pilarska A.

1 Piątkowska K.

1 Zimmermann A.

1 Zimmermann A. E.

Search results

WPŁYW NOWEJ USTAWY O PRODUKTACH KOSMETYCZNYCH NA POPRAWĘ BEZPIECZEŃSTWA ICH STOSOWANIA

Limitation of patients’ rights during the COVID-19 pandemic in Poland